You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

344 Results
Regimen
Cancer Type:
Skin, 
Basal Cell
Intent: Palliative
Apr 2021
Statistical Reports
Statistical Reports
Guidelines and Advice
Jun 2021
Guidelines and Advice
Drug
Other Name(s): Zejula
Mar 2025
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Funding:
Exceptional Access Program
    selpercatinib - For the treatment of metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
Apr 2025
Regimen
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Funding:
New Drug Funding Program
    Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma
New Drug Funding Program
    Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma
Jul 2025
Regimen
Intent: Adjuvant
Jul 2025
Regimen
Intent: Adjuvant
Aug 2024
Il vous est demandé, au travers des questions posées dans l’enquête Votre opinion est importante, d’exprimer votre ressenti quant à votre plus récent...

Pages